Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study-Reference-Cited by-同舟云学术

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study

Published:2017-10-13 Issue:11-12 Volume:46 Page:1077-1084
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Martineau C.¹^ORCID,Flourié B.²,Wils P.³,Vaysse T.⁴,Altwegg R.⁵,Buisson A.⁶^ORCID,Amiot A.⁷,Pineton de Chambrun G.⁵,Abitbol V.⁸,Fumery M.⁹,Hébuterne X.¹⁰,Viennot S.¹¹,Laharie D.¹²,Beaugerie L.¹,Nancey S.²,Sokol H.¹,

Affiliation:

1. Saint Antoine Hospital; Assistance Publique des Hôpitaux de Paris (APHP); CHU; Paris France

2. Lyon Sud Hospital; Hospices Civils de Lyon; CHU; Lyon France

3. Hurriez Hospital; CHU; Lille France

4. Kremlin-Bicêtre Hospital; Assistance Publique des Hôpitaux de Paris (APHP); CHU; Le Kremlin-Bicêtre France

5. Saint-Eloi Hospital; CHU; Montpellier France

6. Clermont Ferrand Hospital; CHU; Clermont-Ferrand France

7. Henri Mondor Hospital; Assistance Publique des Hôpitaux de Paris (APHP); CHU; Créteil France

8. Cochin Hospital; Assistance Publique des Hôpitaux de Paris (APHP); CHU; Paris France

9. Amiens Hospital; CHU; Amiens France

10. De l'Archet Hospital; CHU; Nice France

11. Caen Hospital; CHU; Caen France

12. Haut-Levèque Hospital; CHU; Pessac France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14371/fullpdf

Reference23 articles.

1. Review article: loss of response to anti-TNF treatments in Crohn's disease: review: loss of response to anti-TNF in Crohn's disease;Ben-Horin;Aliment Pharmacol Ther,2011

2. Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis;Nanda;Am J Gastroenterol,2013

3. Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis;Paul;Inflamm Bowel Dis,2014

4. Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial;Khanna;Lancet,2015

5. Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review;Billioud;Am J Gastroenterol,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring treatment: a comprehensive review of precision medicine and biological therapies in inflammatory bowel disease;InterConf;2023-12-20

2. Inflammatory Bowel Diseases and Kidney Transplantation: A Narrative Review of Clinical Management Approaches;Experimental and Clinical Transplantation;2023-10

3. Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach;Journal of Mind and Medical Sciences;2022-04-10

4. Treatment of Inflammatory Bowel Disease: A Comprehensive Review;Frontiers in Medicine;2021-12-20

5. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions;Biologics;2021-08-10